14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EPIX ranks #15491 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

ESSA Pharma Inc. Stock Forecast NASDAQ:EPIX

$8.32 (-4.70%)

Volume: 1M

Closed: Jan 19, 2022

Hollow Logo Score: -4.000

ESSA Pharma Inc. Stock Forecast

$8.32 (-4.70%)

Volume: 1M

Closed: Jan 19, 2022

Score Hollow Logo -4.000

ESSA Pharma Inc. Company Profile

999 West Broadway

Vancouver BC V5Z 1K5



Industry: Biotechnology

Sector: Healthcare

ESSA Pharma Inc.


ESSA Pharma Inc., a clinical-stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE